Showing 1 - 7 results of 7 for search 'Wim G. Goettsch', query time: 0.03s Refine Results
  1. 1
    Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile

    Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile by Ting Wang, Ting Wang, Neil McAuslane, Wim G. Goettsch, Wim G. Goettsch, Hubert G. M. Leufkens, Marie L. De Bruin

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Real World Data in Health Technology Assessment of Complex Health Technologies

    Real World Data in Health Technology Assessment of Complex Health Technologies by Milou A. Hogervorst, Milou A. Hogervorst, Johan Pontén, Rick A. Vreman, Rick A. Vreman, Aukje K. Mantel-Teeuwisse, Wim G. Goettsch, Wim G. Goettsch

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study

    Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study by Rachel R J Kalf, Diana M J Delnoij, Bettina Ryll, Marcel L Bouvy, Wim G Goettsch

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making of oncology medicines

    Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making... by Rachel R. J. Kalf, Rick A. Vreman, Diana M.J. Delnoij, Marcel L. Bouvy, Wim G. Goettsch

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Synergy between health technology assessments and clinical guidelines for multiple sclerosis

    Synergy between health technology assessments and clinical guidelines for multiple sclerosis by Milou A. Hogervorst, Rick A. Vreman, Anna Zawada, Magdalena Zielińska, Dalia M. Dawoud, Brigit A. deJong, Aukje K. Mantel‐Teeuwisse, Wim G. Goettsch

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

    The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs by Rick A. Vreman, Lourens T. Bloem, Stijn van Oirschot, Jarno Hoekman, Menno E. van der Elst, Hubert GM Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel-Teeuwisse

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

    Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies by Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: